EUVIMEDEUVIMED entdecken
Crossref

Investigating the Potential of Nilotinib and its Derivatives in Targeting Tau Protein Hyperphosphorylation for Alzheimer's Disease Treatment

Aria Hajihassan, Atena Zandi, Ghazal Esmaeili, Mostafa Norizadeh

Mathews Journal of Pharmaceutical Science · 2023

DOI: 10.30654/mjps.10025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mathews Journal of Pharmaceutical Science, 2023. Verfasst von Aria Hajihassan und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hajihassan, A., Zandi, A., Esmaeili, G., & Norizadeh, M. (2023). Investigating the Potential of Nilotinib and its Derivatives in Targeting Tau Protein Hyperphosphorylation for Alzheimer's Disease Treatment. Mathews Journal of Pharmaceutical Science. https://doi.org/10.30654/mjps.10025

Vancouver

Hajihassan A, Zandi A, Esmaeili G, Norizadeh M. Investigating the Potential of Nilotinib and its Derivatives in Targeting Tau Protein Hyperphosphorylation for Alzheimer's Disease Treatment. Mathews Journal of Pharmaceutical Science. 2023. doi:10.30654/mjps.10025

BibTeX
@article{Hajihassan2023,
  author = {Hajihassan, Aria and Zandi, Atena and Esmaeili, Ghazal and Norizadeh, Mostafa},
  title = {Investigating the Potential of Nilotinib and its Derivatives in Targeting Tau Protein Hyperphosphorylation for Alzheimer's Disease Treatment},
  journal = {Mathews Journal of Pharmaceutical Science},
  year = {2023},
  doi = {10.30654/mjps.10025}
}
Kostenlos starten →